Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Using new TB tools: global rhetoric and ground reality.

Uplekar M.

Int J Tuberc Lung Dis. 2018 Apr 1;22(4):357. doi: 10.5588/ijtld.18.0082. No abstract available.

PMID:
29562980
2.

Provider initiated tuberculosis case finding in outpatient departments of health care facilities in Ghana: yield by screening strategy and target group.

Ohene SA, Bonsu F, Hanson-Nortey NN, Toonstra A, Sackey A, Lonnroth K, Uplekar M, Danso S, Mensah G, Afutu F, Klatser P, Bakker M.

BMC Infect Dis. 2017 Dec 1;17(1):739. doi: 10.1186/s12879-017-2843-5.

3.

Tuberculosis makes it onto the international political agenda for health…finally.

Raviglione M, Uplekar M, Weil D, Kasaeva T.

Lancet Glob Health. 2018 Jan;6(1):e20-e21. doi: 10.1016/S2214-109X(17)30449-7. Epub 2017 Nov 15. No abstract available.

4.

Mandatory tuberculosis case notification in high tuberculosis-incidence countries: policy and practice.

Uplekar M, Atre S, Wells WA, Weil D, Lopez R, Migliori GB, Raviglione M.

Eur Respir J. 2016 Dec;48(6):1571-1581. doi: 10.1183/13993003.00956-2016. Epub 2016 Oct 20. Review.

5.

Public-private mix for tuberculosis care and prevention. What progress? What prospects?

Uplekar M.

Int J Tuberc Lung Dis. 2016 Nov;20(11):1424-1429.

PMID:
27776581
6.
7.

WHO's End TB Strategy: From stopping to ending the global TB epidemic.

Uplekar M, Raviglione M.

Indian J Tuberc. 2015 Oct;62(4):196-9. doi: 10.1016/j.ijtb.2015.11.001. Epub 2016 Jan 23.

PMID:
26970458
8.

Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.

Getahun H, Matteelli A, Abubakar I, Aziz MA, Baddeley A, Barreira D, Den Boon S, Borroto Gutierrez SM, Bruchfeld J, Burhan E, Cavalcante S, Cedillos R, Chaisson R, Chee CB, Chesire L, Corbett E, Dara M, Denholm J, de Vries G, Falzon D, Ford N, Gale-Rowe M, Gilpin C, Girardi E, Go UY, Govindasamy D, D Grant A, Grzemska M, Harris R, Horsburgh CR Jr, Ismayilov A, Jaramillo E, Kik S, Kranzer K, Lienhardt C, LoBue P, Lönnroth K, Marks G, Menzies D, Migliori GB, Mosca D, Mukadi YD, Mwinga A, Nelson L, Nishikiori N, Oordt-Speets A, Rangaka MX, Reis A, Rotz L, Sandgren A, Sañé Schepisi M, Schünemann HJ, Sharma SK, Sotgiu G, Stagg HR, Sterling TR, Tayeb T, Uplekar M, van der Werf MJ, Vandevelde W, van Kessel F, van't Hoog A, Varma JK, Vezhnina N, Voniatis C, Vonk Noordegraaf-Schouten M, Weil D, Weyer K, Wilkinson RJ, Yoshiyama T, Zellweger JP, Raviglione M.

Eur Respir J. 2015 Dec;46(6):1563-76. doi: 10.1183/13993003.01245-2015. Epub 2015 Sep 24. Review.

9.

Implementing the End TB Strategy: Well begun will be half done.

Uplekar M.

Indian J Tuberc. 2015 Apr;62(2):61-3. doi: 10.1016/j.ijtb.2015.03.001. Epub 2015 Mar 21. No abstract available.

PMID:
26117472
10.

Achieving Systemic and Scalable Private Sector Engagement in Tuberculosis Care and Prevention in Asia.

Wells WA, Uplekar M, Pai M.

PLoS Med. 2015 Jun 23;12(6):e1001842. doi: 10.1371/journal.pmed.1001842. eCollection 2015 Jun. No abstract available.

11.

WHO's new end TB strategy.

Uplekar M, Weil D, Lonnroth K, Jaramillo E, Lienhardt C, Dias HM, Falzon D, Floyd K, Gargioni G, Getahun H, Gilpin C, Glaziou P, Grzemska M, Mirzayev F, Nakatani H, Raviglione M; for WHO's Global TB Programme.

Lancet. 2015 May 2;385(9979):1799-1801. doi: 10.1016/S0140-6736(15)60570-0. Epub 2015 Mar 24. No abstract available.

PMID:
25814376
12.

Towards tuberculosis elimination: an action framework for low-incidence countries.

Lönnroth K, Migliori GB, Abubakar I, D'Ambrosio L, de Vries G, Diel R, Douglas P, Falzon D, Gaudreau MA, Goletti D, González Ochoa ER, LoBue P, Matteelli A, Njoo H, Solovic I, Story A, Tayeb T, van der Werf MJ, Weil D, Zellweger JP, Abdel Aziz M, Al Lawati MR, Aliberti S, Arrazola de Oñate W, Barreira D, Bhatia V, Blasi F, Bloom A, Bruchfeld J, Castelli F, Centis R, Chemtob D, Cirillo DM, Colorado A, Dadu A, Dahle UR, De Paoli L, Dias HM, Duarte R, Fattorini L, Gaga M, Getahun H, Glaziou P, Goguadze L, Del Granado M, Haas W, Järvinen A, Kwon GY, Mosca D, Nahid P, Nishikiori N, Noguer I, O'Donnell J, Pace-Asciak A, Pompa MG, Popescu GG, Robalo Cordeiro C, Rønning K, Ruhwald M, Sculier JP, Simunović A, Smith-Palmer A, Sotgiu G, Sulis G, Torres-Duque CA, Umeki K, Uplekar M, van Weezenbeek C, Vasankari T, Vitillo RJ, Voniatis C, Wanlin M, Raviglione MC.

Eur Respir J. 2015 Apr;45(4):928-52. doi: 10.1183/09031936.00214014. Review.

13.

Beyond UHC: monitoring health and social protection coverage in the context of tuberculosis care and prevention.

Lönnroth K, Glaziou P, Weil D, Floyd K, Uplekar M, Raviglione M.

PLoS Med. 2014 Sep 22;11(9):e1001693. doi: 10.1371/journal.pmed.1001693. eCollection 2014 Sep. Review.

14.

Rebalancing the global battle against tuberculosis.

Raviglione M, Uplekar M, Vincent C, Pablos-Méndez A.

Lancet Glob Health. 2014 Feb;2(2):e71-2. doi: 10.1016/S2214-109X(13)70166-9. Epub 2014 Jan 23. No abstract available.

15.

Updating the International Standards for Tuberculosis Care. Entering the era of molecular diagnostics.

Hopewell PC, Fair EL, Uplekar M.

Ann Am Thorac Soc. 2014 Mar;11(3):277-85. doi: 10.1513/AnnalsATS.201401-004AR.

PMID:
24673691
16.

China tuberculosis policy at crucial crossroads: comparing the practice of different hospital and tuberculosis control collaboration models using survey data.

Wei X, Zou G, Walley J, Yin J, Lonnroth K, Uplekar M, Wang W, Sun Q.

PLoS One. 2014 Mar 12;9(3):e90596. doi: 10.1371/journal.pone.0090596. eCollection 2014. Erratum in: PLoS One. 2014;9(5):e99150.

17.

Programmatic approaches to screening for active tuberculosis.

Uplekar M, Creswell J, Ottmani SE, Weil D, Sahu S, Lönnroth K.

Int J Tuberc Lung Dis. 2013 Oct;17(10):1248-56. doi: 10.5588/ijtld.13.0199.

PMID:
24025375
18.

Scaling up public-private mix: collaborate or regulate?

Uplekar M.

Int J Tuberc Lung Dis. 2013 Sep;17(9):1122. doi: 10.5588/ijtld.13.0577. No abstract available.

PMID:
23928163
19.

Systematic screening for active tuberculosis: rationale, definitions and key considerations.

Lönnroth K, Corbett E, Golub J, Godfrey-Faussett P, Uplekar M, Weil D, Raviglione M.

Int J Tuberc Lung Dis. 2013 Mar;17(3):289-98. doi: 10.5588/ijtld.12.0797. Review.

20.

Working with workplaces for TB care and control.

Uplekar M, Dias M.

Int J Tuberc Lung Dis. 2012 Dec;16(12):1564. doi: 10.5588/ijtld.12.0835. No abstract available.

PMID:
23131251
21.

Global tuberculosis control: lessons learnt and future prospects.

Lienhardt C, Glaziou P, Uplekar M, Lönnroth K, Getahun H, Raviglione M.

Nat Rev Microbiol. 2012 May 14;10(6):407-16. doi: 10.1038/nrmicro2797. Review.

PMID:
22580364
22.

Hospital or home? Scripting a high point in the history of TB care and control.

Uplekar M, Raviglione M.

WHO South East Asia J Public Health. 2012 Apr-Jun;1(2):220-223. doi: 10.4103/2224-3151.206935. No abstract available.

23.

A rapid assessment of prevailing policies on tuberculosis contact investigation.

Hwang TJ, Ottmani S, Uplekar M.

Int J Tuberc Lung Dis. 2011 Dec;15(12):1620-3. doi: 10.5588/ijtld.11.0222.

PMID:
22118168
24.

Cash transfer and microfinance interventions for tuberculosis control: review of the impact evidence and policy implications.

Boccia D, Hargreaves J, Lönnroth K, Jaramillo E, Weiss J, Uplekar M, Porter JDH, Evans CA.

Int J Tuberc Lung Dis. 2011 Jun;15 Suppl 2:37-49. doi: 10.5588/ijtld.10.0438. Review.

25.
26.

Global Fund financing of public-private mix approaches for delivery of tuberculosis care.

Lal SS, Uplekar M, Katz I, Lonnroth K, Komatsu R, Yesudian Dias HM, Atun R.

Trop Med Int Health. 2011 Jun;16(6):685-92. doi: 10.1111/j.1365-3156.2011.02749.x. Epub 2011 Feb 20. Review.

27.

Intensified scale-up of public-private mix: a systems approach to tuberculosis care and control in India.

Lal SS, Sahu S, Wares F, Lönnroth K, Chauhan LS, Uplekar M.

Int J Tuberc Lung Dis. 2011 Jan;15(1):97-104.

PMID:
21276304
28.

Engaging hospitals to meet tuberculosis control targets in China: using the Internet as a tool to put policy into practice.

Wang L, Liu X, Huang F, Hennig C, Uplekar M, Jiang S.

Bull World Health Organ. 2010 Dec 1;88(12):937-42. doi: 10.2471/BLT.09.071753. Epub 2010 Sep 29.

29.

Tuberculosis and noncommunicable diseases: neglected links and missed opportunities.

Creswell J, Raviglione M, Ottmani S, Migliori GB, Uplekar M, Blanc L, Sotgiu G, Lönnroth K.

Eur Respir J. 2011 May;37(5):1269-82. doi: 10.1183/09031936.00084310. Epub 2010 Oct 14. Review.

30.

MDR tuberculosis--critical steps for prevention and control.

Nathanson E, Nunn P, Uplekar M, Floyd K, Jaramillo E, Lönnroth K, Weil D, Raviglione M.

N Engl J Med. 2010 Sep 9;363(11):1050-8. doi: 10.1056/NEJMra0908076. No abstract available.

31.

Tuberculosis management by private practitioners in Mumbai, India: has anything changed in two decades?

Udwadia ZF, Pinto LM, Uplekar MW.

PLoS One. 2010 Aug 9;5(8):e12023. doi: 10.1371/journal.pone.0012023.

32.

Economic evaluation of public-private mix for tuberculosis care and control, India. Part II. Cost and cost-effectiveness.

Pantoja A, Lönnroth K, Lal SS, Chauhan LS, Uplekar M, Padma MR, Unnikrishnan KP, Rajesh J, Kumar P, Sahu S, Wares F, Floyd K.

Int J Tuberc Lung Dis. 2009 Jun;13(6):705-12.

PMID:
19460245
33.

Economic evaluation of public-private mix for tuberculosis care and control, India. Part I. Socio-economic profile and costs among tuberculosis patients.

Pantoja A, Floyd K, Unnikrishnan KP, Jitendra R, Padma MR, Lal SS, Uplekar M, Chauhan LS, Kumar P, Sahu S, Wares F, Lönnroth K.

Int J Tuberc Lung Dis. 2009 Jun;13(6):698-704.

PMID:
19460244
34.

PPM: 'public-private' or 'private-public' mix? The case of Ujjain District, India.

De Costa A, Kazmi T, Lönnroth K, Uplekar M, Diwan VK.

Int J Tuberc Lung Dis. 2008 Nov;12(11):1333-5.

PMID:
18926046
35.

Public-private mix for control of tuberculosis and TB-HIV in Nairobi, Kenya: outcomes, opportunities and obstacles.

Chakaya J, Uplekar M, Mansoer J, Kutwa A, Karanja G, Ombeka V, Muthama D, Kimuu P, Odhiambo J, Njiru H, Kibuga D, Sitienei J.

Int J Tuberc Lung Dis. 2008 Nov;12(11):1274-8.

PMID:
18926037
36.

Stopping tuberculosis: time to turn urgent attention to hospitals.

Uplekar M.

Int J Tuberc Lung Dis. 2008 Sep;12(9):986. No abstract available.

PMID:
18713493
37.

Social and cultural dimensions of gender and tuberculosis.

Weiss MG, Sommerfeld J, Uplekar MW.

Int J Tuberc Lung Dis. 2008 Jul;12(7):829-30. No abstract available.

PMID:
18544212
38.

Gender and TB: pointers from routine records and reports.

Ottmani SE, Uplekar MW.

Int J Tuberc Lung Dis. 2008 Jul;12(7):827-8. No abstract available.

PMID:
18544211
39.

The "vertical-horizontal" debates: time for the pendulum to rest (in peace)?

Uplekar M, Raviglione MC.

Bull World Health Organ. 2007 May;85(5):413-4. No abstract available.

40.

MDR and XDR - the price of delaying engagement with all care providers for control of TB and TB/HIV.

Uplekar M, Lönnroth K.

Trop Med Int Health. 2007 Apr;12(4):473-4. No abstract available.

41.

Social franchising of TB care through private GPs in Myanmar: an assessment of treatment results, access, equity and financial protection.

Lönnroth K, Aung T, Maung W, Kluge H, Uplekar M.

Health Policy Plan. 2007 May;22(3):156-66. Epub 2007 Apr 12.

PMID:
17434870
42.

Hard gains through soft contracts: productive engagement of private providers in tuberculosis control.

Lönnroth K, Uplekar M, Blanc L.

Bull World Health Organ. 2006 Nov;84(11):876-83.

43.

International standards for tuberculosis care.

Hopewell PC, Pai M, Maher D, Uplekar M, Raviglione MC.

Lancet Infect Dis. 2006 Nov;6(11):710-25. Review.

PMID:
17067920
44.

Private GPs contribute to TB control in Myanmar: evaluation of a PPM initiative in Mandalay Division.

Maung M, Kluge H, Aye T, Maung W, Noe P, Zaw M, Jost SP, Uplekar M, Lönnroth K.

Int J Tuberc Lung Dis. 2006 Sep;10(9):982-7.

PMID:
16964788
45.

Turning liabilities into resources: informal village doctors and tuberculosis control in Bangladesh.

Hamid Salim MA, Uplekar M, Daru P, Aung M, Declercq E, Lönnroth K.

Bull World Health Organ. 2006 Jun;84(6):479-84. Epub 2006 Jun 21.

46.

Cost and cost-effectiveness of PPM-DOTS for tuberculosis control: evidence from India.

Floyd K, Arora VK, Murthy KJ, Lonnroth K, Singla N, Akbar Y, Zignol M, Uplekar M.

Bull World Health Organ. 2006 Jun;84(6):437-45. Epub 2006 Jun 21.

47.

WHO's new Stop TB Strategy.

Raviglione MC, Uplekar MW.

Lancet. 2006 Mar 18;367(9514):952-5. No abstract available.

PMID:
16546550
48.

Improving tuberculosis control through public-private collaboration in India: literature review.

Dewan PK, Lal SS, Lonnroth K, Wares F, Uplekar M, Sahu S, Granich R, Chauhan LS.

BMJ. 2006 Mar 11;332(7541):574-8. Epub 2006 Feb 8. Review.

49.

Invest in breaking the barriers of public-private collaboration for improved tuberculosis care.

Lönnroth K, Uplekar M.

Bull World Health Organ. 2005 Jul;83(7):558-9. No abstract available.

50.

Every provider counts: effect of a comprehensive public-private mix approach for TB control in a large metropolitan area in India.

Ambe G, Lönnroth K, Dholakia Y, Copreaux J, Zignol M, Borremans N, Uplekar M.

Int J Tuberc Lung Dis. 2005 May;9(5):562-8.

PMID:
15875930

Supplemental Content

Loading ...
Support Center